| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |